Oförändrat substansvärde sekventiellt Karolinska Development redovisar ett totalt verkligt värde om ...
Rapportkommentar Egetis släppte under onsdagen sin rapport för det fjärde kvartalet.
Redeye endorses SenzaGen’s new GARDskin order of SEK1m from a new customer within the chemical indus...
Investmentbolaget Archelon investerar främst i prospekteringsbolag inom gruvnäring, men innehar även...
Cibus posted Q4 net operating income of EUR 26.5m, up 30% y/y on the back of acquisitions and 1% abo...
Redeye provides a first comment on the back of Northbaze Group’s Q4 report.
Good Q4 despite one-off'sStrong order intake. Order book in-lineGuidance 5 -16% above our expectatio...
Temenos' SaaS sales grew 32% in 2022 Earlier this week, Formpipe's banking platform partner, Temenos...
Redeye provides a research update on Alzinova following the company’s Q4 report published earlier to...
Devyser lämnar ett starkt helår bakom sig och står välrustade inför ett högintressant 2023.
Redeye states its view of Infracom’s Q4 report revealed earlier today.
Redeye concludes that Q4 was stronger than expected, both on revenues and much above on EBIT.
Redeye comments on Beyond Frames Q4’22 report, where net sales came in significantly below forecast.
Redeye provides an update on Thunderful Group following its Q4 2022 report which was released on Feb...
Redeye gives an initial take on Binero’s Q4 2022 report.
Calliditas recorded Q4 Tarpeyo sales of SEK 169m which is slightly below our and the markets expecta...
Redeye comments on Fragbite Groups Q4’22 report, which was in line with our sales forecast but sligh...
Efter stora förändringar av både värdena på portföljinnehaven såväl som själva portföljen lägger Nor...
Redeye thinks that the Q4 report was indeed weak, but that the stock market's reaction was too big.
Redeye updates its estimates following Freemelt’s Q4 report, which came in lower than expected due t...
